vs
FLOTEK INDUSTRIES INC（FTK）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是FLOTEK INDUSTRIES INC的1.9倍（$127.1M vs $67.5M），FLOTEK INDUSTRIES INC同比增速更快（33.0% vs 17.1%），过去两年FLOTEK INDUSTRIES INC的营收复合增速更高（29.3% vs 20.8%）
Flotek Industries是一家技术驱动的多元化企业，主要开发和供应特种化学品、高性能材料及相关设备解决方案，服务全球能源、采矿和工业制造领域，助力客户提升运营效率。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
FTK vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.9倍
$67.5M
营收增速更快
FTK
高出15.9%
17.1%
两年增速更快
FTK
近两年复合增速
20.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.5M | $127.1M |
| 净利润 | $3.0M | — |
| 毛利率 | 22.5% | 51.0% |
| 营业利润率 | 8.9% | -54.6% |
| 净利率 | 4.5% | — |
| 营收同比 | 33.0% | 17.1% |
| 净利润同比 | -31.7% | — |
| 每股收益（稀释后） | $0.09 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FTKZLAB
| Q4 25 | $67.5M | $127.1M | ||
| Q3 25 | $56.0M | $115.4M | ||
| Q2 25 | $58.4M | $109.1M | ||
| Q1 25 | $55.4M | $105.7M | ||
| Q4 24 | $50.8M | $108.5M | ||
| Q3 24 | $49.7M | $101.8M | ||
| Q2 24 | $46.2M | $100.1M | ||
| Q1 24 | $40.4M | $87.1M |
净利润FTKZLAB
| Q4 25 | $3.0M | — | ||
| Q3 25 | $20.4M | $-36.0M | ||
| Q2 25 | $1.8M | $-40.7M | ||
| Q1 25 | $5.4M | $-48.4M | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $2.5M | $-41.7M | ||
| Q2 24 | $2.0M | $-80.3M | ||
| Q1 24 | $1.6M | $-53.5M |
毛利率FTKZLAB
| Q4 25 | 22.5% | 51.0% | ||
| Q3 25 | 31.7% | 59.5% | ||
| Q2 25 | 24.7% | 60.6% | ||
| Q1 25 | 22.5% | 63.6% | ||
| Q4 24 | 24.2% | 61.5% | ||
| Q3 24 | 18.3% | 64.1% | ||
| Q2 24 | 19.9% | 64.9% | ||
| Q1 24 | 21.8% | 61.4% |
营业利润率FTKZLAB
| Q4 25 | 8.9% | -54.6% | ||
| Q3 25 | 16.2% | -42.3% | ||
| Q2 25 | 4.4% | -50.3% | ||
| Q1 25 | 10.1% | -53.3% | ||
| Q4 24 | 10.1% | -62.6% | ||
| Q3 24 | 5.5% | -66.6% | ||
| Q2 24 | 4.8% | -76.0% | ||
| Q1 24 | 5.2% | -80.7% |
净利率FTKZLAB
| Q4 25 | 4.5% | — | ||
| Q3 25 | 36.3% | -31.2% | ||
| Q2 25 | 3.0% | -37.3% | ||
| Q1 25 | 9.7% | -45.8% | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | 5.1% | -40.9% | ||
| Q2 24 | 4.3% | -80.2% | ||
| Q1 24 | 3.9% | -61.4% |
每股收益（稀释后）FTKZLAB
| Q4 25 | $0.09 | $-0.05 | ||
| Q3 25 | $0.53 | $-0.03 | ||
| Q2 25 | $0.05 | $-0.04 | ||
| Q1 25 | $0.17 | $-0.04 | ||
| Q4 24 | $0.15 | $-0.09 | ||
| Q3 24 | $0.08 | $-0.04 | ||
| Q2 24 | $0.06 | $-0.08 | ||
| Q1 24 | $0.05 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.7M | $689.6M |
| 总债务越低越好 | $40.0M | — |
| 股东权益账面价值 | $113.1M | $715.5M |
| 总资产 | $220.0M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.35× | — |
8季度趋势，按日历期对齐
现金及短期投资FTKZLAB
| Q4 25 | $5.7M | $689.6M | ||
| Q3 25 | $4.6M | $717.2M | ||
| Q2 25 | $5.0M | $732.2M | ||
| Q1 25 | $6.3M | $757.3M | ||
| Q4 24 | $4.4M | $779.7M | ||
| Q3 24 | $5.0M | $616.1M | ||
| Q2 24 | $4.8M | $630.0M | ||
| Q1 24 | $5.2M | $650.8M |
总债务FTKZLAB
| Q4 25 | $40.0M | — | ||
| Q3 25 | $40.0M | — | ||
| Q2 25 | $40.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $194.0K | — |
股东权益FTKZLAB
| Q4 25 | $113.1M | $715.5M | ||
| Q3 25 | $110.5M | $759.9M | ||
| Q2 25 | $71.8M | $791.7M | ||
| Q1 25 | $119.7M | $810.8M | ||
| Q4 24 | $113.9M | $840.9M | ||
| Q3 24 | $109.0M | $667.7M | ||
| Q2 24 | $106.2M | $704.2M | ||
| Q1 24 | $103.9M | $762.2M |
总资产FTKZLAB
| Q4 25 | $220.0M | $1.2B | ||
| Q3 25 | $212.7M | $1.2B | ||
| Q2 25 | $172.2M | $1.2B | ||
| Q1 25 | $170.2M | $1.2B | ||
| Q4 24 | $170.8M | $1.2B | ||
| Q3 24 | $160.6M | $985.3M | ||
| Q2 24 | $156.0M | $987.4M | ||
| Q1 24 | $155.8M | $988.4M |
负债/权益比FTKZLAB
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.56× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.2M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 2.07× | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流FTKZLAB
| Q4 25 | $6.2M | $-26.0M | ||
| Q3 25 | $-1.9M | $-32.0M | ||
| Q2 25 | $-4.5M | $-31.0M | ||
| Q1 25 | $7.3M | $-61.7M | ||
| Q4 24 | $-2.6M | $-55.8M | ||
| Q3 24 | $5.1M | $-26.8M | ||
| Q2 24 | $-3.1M | $-42.2M | ||
| Q1 24 | $3.9M | $-90.1M |
自由现金流FTKZLAB
| Q4 25 | — | $-26.7M | ||
| Q3 25 | — | $-35.0M | ||
| Q2 25 | — | $-33.9M | ||
| Q1 25 | — | $-63.2M | ||
| Q4 24 | — | $-58.4M | ||
| Q3 24 | — | $-28.2M | ||
| Q2 24 | — | $-42.9M | ||
| Q1 24 | — | $-91.1M |
自由现金流率FTKZLAB
| Q4 25 | — | -21.0% | ||
| Q3 25 | — | -30.4% | ||
| Q2 25 | — | -31.1% | ||
| Q1 25 | — | -59.9% | ||
| Q4 24 | — | -53.8% | ||
| Q3 24 | — | -27.7% | ||
| Q2 24 | — | -42.9% | ||
| Q1 24 | — | -104.5% |
资本支出强度FTKZLAB
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.1% |
现金转化率FTKZLAB
| Q4 25 | 2.07× | — | ||
| Q3 25 | -0.09× | — | ||
| Q2 25 | -2.54× | — | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | -0.58× | — | ||
| Q3 24 | 2.01× | — | ||
| Q2 24 | -1.55× | — | ||
| Q1 24 | 2.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FTK
| Related Party | $49.6M | 74% |
| Nonrelated Party | $17.9M | 26% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
